Metformin Inhibits the Development of l-DOPA-Induced Dyskinesia in a Murine Model of Parkinson’s Disease
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin Inhibits the Development of l-DOPA-Induced Dyskinesia in a Murine Model of Parkinson’s Disease
Authors
Keywords
Parkinson’s disease, <span class=EmphasisTypeSmallCaps >l, Metformin, Glycogen synthase kinase 3β
Journal
MOLECULAR NEUROBIOLOGY
Volume 55, Issue 7, Pages 5715-5726
Publisher
Springer Nature
Online
2017-10-16
DOI
10.1007/s12035-017-0752-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin protects the brain against ischemia/reperfusion injury through PI3K/Akt1/JNK3 signaling pathways in rats
- (2017) Xu-Hua Ge et al. PHYSIOLOGY & BEHAVIOR
- Gadd45β ameliorates L-DOPA-induced dyskinesia in a Parkinson's disease mouse model
- (2016) Hye-Yeon Park et al. NEUROBIOLOGY OF DISEASE
- Inhibition of Glycogen Synthase Kinase-3β (GSK-3β) as potent therapeutic strategy to ameliorates L-dopa-induced dyskinesia in 6-OHDA parkinsonian rats
- (2016) Cheng-long Xie et al. Scientific Reports
- Metformin and gefitinib cooperate to inhibit bladder cancer growth via both AMPK and EGFR pathways joining at Akt and Erk
- (2016) Mei Peng et al. Scientific Reports
- New treatments for levodopa-induced motor complications
- (2015) Olivier Rascol et al. MOVEMENT DISORDERS
- Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study)
- (2015) Rajesh Pahwa et al. MOVEMENT DISORDERS
- M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia
- (2015) Weixing Shen et al. NEURON
- Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease
- (2015) Mojtaba Golpich et al. PHARMACOLOGICAL RESEARCH
- Ribosomal Protein S6 Phosphorylation in the Nervous System: From Regulation to Function
- (2015) Anne Biever et al. Frontiers in Molecular Neuroscience
- Metformin Treatment in the Period After Stroke Prevents Nitrative Stress and Restores Angiogenic Signaling in the Brain in Diabetes
- (2014) Mohammed Abdelsaid et al. DIABETES
- Inhibition of Adenylyl Cyclase Type 5 Prevents L-DOPA-Induced Dyskinesia in an Animal Model of Parkinson's Disease
- (2014) H.-Y. Park et al. JOURNAL OF NEUROSCIENCE
- Metformin—mode of action and clinical implications for diabetes and cancer
- (2014) Ida Pernicova et al. Nature Reviews Endocrinology
- Neuroprotective effect of metformin in MPTP-induced Parkinson’s disease in mice
- (2014) S.P. Patil et al. NEUROSCIENCE
- Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias
- (2014) Olivier Rascol et al. PARKINSONISM & RELATED DISORDERS
- Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide
- (2014) Krzysztof Łabuzek et al. Pharmacological Reports
- Cell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia
- (2014) Tim Fieblinger et al. Nature Communications
- Serotonin System Implication in l-DOPA-Induced Dyskinesia: From Animal Models to Clinical Investigations
- (2014) Manolo Carta et al. Frontiers in Neurology
- The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro
- (2013) Marija Dulovic et al. NEUROBIOLOGY OF DISEASE
- Withdrawing amantadine in dyskinetic patients with Parkinson disease: The AMANDYSK trial
- (2013) F. Ory-Magne et al. NEUROLOGY
- Haloperidol promotes mTORC1-dependent phosphorylation of ribosomal protein S6 via dopamine- and cAMP-regulated phosphoprotein of 32 kDa and inhibition of protein phosphatase-1
- (2013) Alessandra Bonito-Oliva et al. NEUROPHARMACOLOGY
- Activity-dependent regulation of dendritic growth and maintenance by glycogen synthase kinase 3β
- (2013) Yanfang Rui et al. Nature Communications
- Metformin improves healthspan and lifespan in mice
- (2013) Alejandro Martin-Montalvo et al. Nature Communications
- Targeting Glutamate Receptors to Tackle the Pathogenesis, Clinical Symptoms and Levodopa-Induced Dyskinesia Associated with Parkinson’s Disease
- (2012) Susan Duty CNS DRUGS
- AMP Kinase Activation Mitigates Dopaminergic Dysfunction and Mitochondrial Abnormalities in Drosophila Models of Parkinson's Disease
- (2012) C.-H. Ng et al. JOURNAL OF NEUROSCIENCE
- Effects of metformin on learning and memory behaviors and brain mitochondrial functions in high fat diet induced insulin resistant rats
- (2012) Hiranya Pintana et al. LIFE SCIENCES
- Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort
- (2012) Mark L. Wahlqvist et al. PARKINSONISM & RELATED DISORDERS
- Deletion of GSK3 in D2R-expressing neurons reveals distinct roles for -arrestin signaling in antipsychotic and lithium action
- (2012) N. M. Urs et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levels
- (2011) Simone Bido et al. JOURNAL OF NEUROCHEMISTRY
- SNCA,MAPT, andGSK3Bin Parkinson disease: a gene-gene interaction study
- (2010) C. Wider et al. EUROPEAN JOURNAL OF NEUROLOGY
- Involvment of Cytosolic and Mitochondrial GSK-3β in Mitochondrial Dysfunction and Neuronal Cell Death of MPTP/MPP+-Treated Neurons
- (2009) Agnès Petit-Paitel et al. PLoS One
- Inhibition of mTOR Signaling in Parkinson's Disease Prevents L-DOPA-Induced Dyskinesia
- (2009) E. Santini et al. Science Signaling
- Akt/GSK3 Signaling in the Action of Psychotropic Drugs
- (2008) Jean-Martin Beaulieu et al. Annual Review of Pharmacology and Toxicology
- The role of GSK-3 in synaptic plasticity
- (2008) S Peineau et al. BRITISH JOURNAL OF PHARMACOLOGY
- l-DOPA activates ERK signaling and phosphorylates histone H3 in the striatonigral medium spiny neurons of hemiparkinsonian mice
- (2008) Emanuela Santini et al. JOURNAL OF NEUROCHEMISTRY
- Molecular mechanisms of L-DOPA-induced dyskinesia
- (2008) Peter Jenner NATURE REVIEWS NEUROSCIENCE
- Glycogen synthase kinase-3beta is associated with Parkinson's disease
- (2008) Masahiro Nagao et al. NEUROSCIENCE LETTERS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started